@article{41753,
      author = {Athanasiadou, Amalia.},
      url = {http://tind.wipo.int/record/41753},
      title = {Patent Settlements in the Pharmaceutical Industry under US  Antitrust and EU Competition Law.},
      abstract = {Patent Settlements in the Pharmaceutical Industry under US  Antitrust and EU Competition Law examines patent  settlements between originators and generic pharmaceutical  manufacturers under United States (US) antitrust and  European Union (EU) competition law. The major focus is on  patent settlements involving reverse payments, commonly  known as “pay-for-delay” settlements. Reverse payment  settlements or “pay-for-delay agreements” create heated  debates regarding the balance between competition and  intellectual property law. These settlements touch upon  sensitive issues such as timely generic entry and access to  affordable pharmaceuticals on the one hand and the need to  preserve innovation incentives for originators and to  strengthen the pipeline of life-saving pharmaceuticals on  the other hand. This book is one of the first to analyse  critically and comparatively how such patent settlements  and various other strategies employed by the pharmaceutical  industry are scrutinised by US and European courts as well  as enforcement authorities, focusing on the applicable  legal tests and the main criteria used by courts and  enforcement authorities when applying antitrust scrutiny.},
      recid = {41753},
      pages = {xxxi, 479 pages ;},
}